Kidney cancer

Showing 2 posts of 32 posts found.

GSK’s Votrient approved in Europe

June 16, 2010
Sales and Marketing GlaxoSmithKline, Kidney cancer, Votrient

The European Commission has granted a conditional marketing authorisation for a GlaxoSmithKline drug that treats the most common form of …

NICE criticised for rejection of kidney cancer drugs

August 27, 2009
Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …

The Gateway to Local Adoption Series

Latest content